Matches in Wikidata for { <http://www.wikidata.org/entity/Q96162464> ?p ?o ?g. }
Showing items 1 to 33 of
33
with 100 items per page.
- Q96162464 description "artículu científicu espublizáu en xunu de 2020" @default.
- Q96162464 description "scientific article published on 05 June 2020" @default.
- Q96162464 description "wetenschappelijk artikel" @default.
- Q96162464 description "наукова стаття, опублікована 5 червня 2020" @default.
- Q96162464 name "Angiotensin converting enzyme 2 (ACE2) and COVID-19: using antihypertensive medications, pharmacogenetic considerations" @default.
- Q96162464 name "Angiotensin converting enzyme 2 (ACE2) and COVID-19: using antihypertensive medications, pharmacogenetic considerations" @default.
- Q96162464 type Item @default.
- Q96162464 label "Angiotensin converting enzyme 2 (ACE2) and COVID-19: using antihypertensive medications, pharmacogenetic considerations" @default.
- Q96162464 label "Angiotensin converting enzyme 2 (ACE2) and COVID-19: using antihypertensive medications, pharmacogenetic considerations" @default.
- Q96162464 prefLabel "Angiotensin converting enzyme 2 (ACE2) and COVID-19: using antihypertensive medications, pharmacogenetic considerations" @default.
- Q96162464 prefLabel "Angiotensin converting enzyme 2 (ACE2) and COVID-19: using antihypertensive medications, pharmacogenetic considerations" @default.
- Q96162464 P1433 Q96162464-4E45AF61-9363-4332-A832-022BA12AE93A @default.
- Q96162464 P1476 Q96162464-5F62F9A3-82E7-43D4-940B-CD45157959FD @default.
- Q96162464 P2093 Q96162464-28B45F18-0D74-4708-BB9D-00ED0E10E6C7 @default.
- Q96162464 P2093 Q96162464-615BD8F8-B84A-4C2B-9918-8D66FC16F08F @default.
- Q96162464 P31 Q96162464-B9FA1E0D-39CF-495C-AF7A-F630BE2FE6F3 @default.
- Q96162464 P356 Q96162464-260BF5D1-47F6-44E6-B671-B514F08119AD @default.
- Q96162464 P577 Q96162464-0226F647-3E6E-45F4-9020-0BDBD454F8DF @default.
- Q96162464 P698 Q96162464-58F03E41-2BD1-4DE5-A4DB-D5546C384A81 @default.
- Q96162464 P921 Q96162464-C5747C23-2D22-40DA-896D-3F2E68B4BD04 @default.
- Q96162464 P932 Q96162464-B1EC968D-ACE1-423B-BCA9-12BFFBE9636F @default.
- Q96162464 P356 PGS-2020-0048 @default.
- Q96162464 P698 32501190 @default.
- Q96162464 P1433 Q15724625 @default.
- Q96162464 P1476 "Angiotensin converting enzyme 2 (ACE2) and COVID-19: using antihypertensive medications, pharmacogenetic considerations" @default.
- Q96162464 P2093 "Bruce D Johnson" @default.
- Q96162464 P2093 "Eric M Snyder" @default.
- Q96162464 P31 Q13442814 @default.
- Q96162464 P356 "10.2217/PGS-2020-0048" @default.
- Q96162464 P577 "2020-06-05T00:00:00Z" @default.
- Q96162464 P698 "32501190" @default.
- Q96162464 P921 Q84263196 @default.
- Q96162464 P932 "7373206" @default.